Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,819,325 papers from all fields of science
Search
Sign In
Create Free Account
DAT regimen
Known as:
Daunorubicin-AraC-Thioguanine Regimen
, Daunorubicin-Cytarabine-Thioguanine Regimen
, MRC AML10 Study-DAT Regimen
A regimen consisting of daunorubicin, cytarabine (Ara-C) and thioguanine, used as an induction treatment for childhood acute myeloid leukemia (AML).
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Cytarabine
Daunorubicin
TAD regimen
Thioguanine
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
University of Twente
J. Entzinger
The Grants Register
2018
Corpus ID: 53866556
This thesis deals with the problem of seam detection for robotic laser welding applications. Within the Mechanical Automation…
Expand
2016
2016
Increased Expression of EGR-1 in Diabetic Human Adipose Tissue-Derived Mesenchymal Stem Cells Reduces Their Wound Healing Capacity.
Nhu-Thuy Trinh
,
T. Yamashita
,
+4 authors
O. Ohneda
Stem cells and development
2016
Corpus ID: 36641105
The prevalence of type 2 diabetes mellitus (T2DM), which leads to diabetic complications, has been increasing worldwide. The…
Expand
Highly Cited
2014
Highly Cited
2014
Reduced Dopamine Transporter Functioning Induces High-Reward Risk-Preference Consistent with Bipolar Disorder
J. Enkhuizen
,
Brook L. Henry
,
+5 authors
Jared W. Young
Neuropsychopharmacology
2014
Corpus ID: 10125825
Individuals with bipolar disorder (BD) exhibit deleterious decision making, negatively impacting their lives. Such aberrant…
Expand
2013
2013
Characterization of direct antiglobulin test‐negative autoimmune hemolytic anemia: A study of 154 cases
T. Kamesaki
,
T. Toyotsuji
,
E. Kajii
American journal of hematology
2013
Corpus ID: 25965731
Direct antiglobulin test (DAT)‐negative (DAT‐)autoimmune hemolytic anemia (AIHA) is empirically thought to show the same clinical…
Expand
2012
2012
Dopamine transporter binding in social anxiety disorder: the effect of treatment with escitalopram
J. Warwick
,
P. Carey
,
+6 authors
Dan J Stein
Metabolic Brain Disease
2012
Corpus ID: 7825253
Social anxiety disorder (SAD) is characterised by fear of social or performance situations where the individual is exposed to…
Expand
Highly Cited
2011
Highly Cited
2011
Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania
Jared W. Young
,
Jordy van Enkhuizen
,
C. Winstanley
,
M. Geyer
Journal of psychopharmacology
2011
Corpus ID: 22806292
Reduced functioning of the dopamine transporter (DAT) has been linked to bipolar disorder (BD). Mice with reduced DAT functioning…
Expand
Highly Cited
1990
Highly Cited
1990
MACA-a New Channel Access Method for Packet Radio
P. Karn
1990
Corpus ID: 33797985
n a The existing Carrier Sense Multiple Access (CSMA) method widely used i mateur packet radio on shared simplex packet radio…
Expand
1988
1988
Aclacinomycin A and etoposide (VP-16-213): an effective regimen in previously treated patients with refractory acute myelogenous leukemia.
J. Rowe
,
A. Chang
,
J. Bennett
Blood
1988
Corpus ID: 24664369
Thirty-five patients with acute myelogenous leukemia were treated with aclacinomycin A (60 mg/m2/day for 5 days) and VP-16-213…
Expand
Highly Cited
1986
Highly Cited
1986
Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukemia.
J. Reiffers
,
P. Bernard
,
+5 authors
A. Broustet
Experimental hematology
1986
Corpus ID: 26457227
One patient with acute nonlymphocytic leukemia (ANLL) in remission was given intensive chemotherapy (DAT regimen) as late…
Expand
1980
1980
Blast cell kinetics and prognosis in acute nonlymphocytic leukemia.
S. Amadori
,
M. Petti
,
C. Mastrovincenzo
,
M. G. Testa
,
A. Antonelli
,
F. Mandelli
Leukemia research
1980
Corpus ID: 44488048
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE